The Ithaca Voice is an online-only nonprofit news site serving Ithaca and Tompkins County. Stacy Giles (’92) won the … The study also demonstrated a median DOR of 12.6 months (95% CI, 5.5-25.3 months) in treatment-naive patients (19 responders) and 9.7 months (95% CI, 5.5-13 months) in previously treated patients (28 responders). CIG is the UK’s leading provider of sector-specific content, publishing 15 healthcare and beauty titles including Pharmacy Magazine, Training Matters, P3Pharmacy, Independent Community Pharmacist and … Cancer medications dominate the field. FDA issued an emergency use authorization (EUA) on Friday, December 11, for the Pfizer/BioNTech COVID-19 vaccine, which is indicated for those ages 16 years and older. CVS had announced over a year ago that it would close 75 stores in 2020, after shuttering 46 in 2019, according to the analysis by the website Retail Info Systems. The safety and efficacy of factor VIIa (recombinant)-jncw were evaluated in 27 patients with hemophilia A or B with inhibitors, which included treatment of 465 mild or moderate episodes and three severe bleeding episodes. That has been a crucial part of a massive undertaking. Joseph P. Balthasar, BS ’91 & PhD ’96, Professor of Pharmaceutical Sciences, Executive Director of University Research Initiatives, and Director of the Center for Protein Therapeutics, has been named the first David and Jane Chu Endowed Chair in Drug Discovery and Development in the University at Buffalo School of Pharmacy … “Clinical trials showed ... almost 85% of patients experiencing tumor shrinkage with this targeted drug,” said Richard Pazdur, MD, the director of the FDA’s Oncology Center of Excellence. For years, specialty drugs have dominated new drug approvals, and 2020 was no different. “More broadly, because he very publicly supported health care access and affordability when he was serving in Congress, I believe that he will prove to be a strong ally for pharmacists.”. The data showed that in patients with relapsed cancer, lurbinectedin demonstrated an ORR of 35% and a median DOR of 5.3 months (30%) (Lancet Oncol 2020;21[5]:645-654). The treatment of small cell lung cancer (SCLC) also advanced in 2020 with the approval of lurbinectedin (Zepzelca, Jazz/PharmaMar), an alkylating agent that is infused every 21 days. > news > The Ten Pharmacy Trends to Watch Out For in 2020. “It was particularly effective in patients with brain metastases,” she said. The FDA approved sacituzumab govitecan-hziy based on a clinical trial of 108 patients with metastatic TNBC who had received at least two prior treatments for metastatic disease. MAJ Joseph Remesz-Guerrette, PharmD, U.S. Army, has had plenty of experience in the storage and handling of pharmaceuticals over his decade or so in pharmacy. The disorders result from the buildup of defective progerin or progerin-like protein in cells. G. Zumach, Kerry K. Fierke , associate professor, and W. D. Maxwell had their article, “ Utilizing a virtual symposium to engage membership ,” published in The Mortar Board , a publication of the International Pharmaceutical Federation Academic Pharmacy … The form, used by DEA registrants to report thefts or significant losses of controlled sub-stances (CS), would also need to be submitted within a 15-day time period under the proposed rule. By the end of 2020, the FDA is expected to approve 21 novel cancer drugs, she noted. CIG is the UK’s leading provider of sector-specific content, publishing 15 healthcare and beauty titles including Pharmacy … The approval of capmatinib is based on results from the pivotal GEOMETRY study. Immunotherapy Toxicities ... Pharmacy Practice News (PPN) strives to provide health-system pharmacists with accurate, relevant and up-to-date information that improves their clinical practice. © Copyright 2020, American Pharmacists Association All Rights Reserved. Isatuximab-irfc binds to the CD38 receptor on multiple myeloma cells. They will combine Dr. Fein’s expertise and cutting-edge analysis—such as this 2020 Economic Report on U.S. Pharmacies and Pharmacy … The median PFS in patients who received tucatinib plus trastuzumab-capecitabine was 7.8 months compared with 5.6 months for placebo. 2020… Sacituzumab govitecan-hziy (Trodelvy, Immunomedics), an antibody drug conjugate for the third-line treatment of metastatic triple-negative breast cancer (TNBC), was another noteworthy oncology drug approval, Tharaldson said. For all of these reasons, Drug Store News has named Rite Aid its 2020 Pharmacy Innovator of the Year. Ozanimod (Zeposia, Bristol Myers Squibb), a sphingosine 1-phosphate receptor modulator, was approved for relapsing/remitting forms of multiple sclerosis. Two owners of a dozen New York City-area pharmacies have been charged for their reported involvement in a $30 million health care fraud and money laundering scheme, a press release Tuesday … FDA's vaccine advisory panel on Thursday voted 17-4 to recommend regulatory emergency authorization of Pfizer and BioNTech's COVID-19 vaccine, which the agency is expected to push forward within a matter of days. In this Motley Fool Live video recorded on Dec. 16, 2020, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights talk about which one of these pharmacy … National Pharmacy Compliance News. Coagulation factor VIIa (recombinant)-jncw (Sevenfact, LFB S.A.) was approved to control episodes in patients with hemophilia A or B with inhibitors by bypassing the parts of the coagulation pathway that are blocked by inhibitors. In the ICARIA-MM study, isatuximab-irfc plus pom-dex demonstrated a statistically significant improvement in progression-free survival (PFS), with a median PFS of 11.53 months compared with 6.47 months with pom-dex alone (hazard ratio, 0.596; 95% CI, 0.44-0.81; P=0.0010). To maximize access to COVID-19 vaccines for all Americans, the U.S. Department of Health and Human Services (HHS) today announced the U.S. government’s partnerships with large chain pharmacies and networks that represent independent pharmacies and regional chains. Contributors are expected to conduct themselves in an appropriate manner, refraining from personal attacks and profane, coarse or abusive language. “Chemotherapy has been the mainstay of treatment for triple-negative breast cancer,” the FDA’s Pazdur said. “This is the first drug approved to treat this condition, which is typically treated with surgery and chemotherapy,” Tharaldson said. Category News index page. November. In the MET exon 14 population (n=97), the confirmed ORR was 68% (95% CI, 48%-84%) and 41% (95% CI, 29%-53%) among treatment-naive (n=28) and previously treated patients (n=69), respectively. Last year, specialty drugs accounted for about 48% of the drug spend, and it’s been inching up, according to the “Express Scripts 2019 Drug Trend Report” (bit.ly/3kO36EN). Risdiplam (Evrysdi, Genentech), a survival of motor neuron 2 (SMN2) splicing modifier, was approved for the treatment of spinal muscular atrophy. Ripretinib (Qinlock, Deciphere), an oral TKI for the fourth-line treatment of advanced GIST, also was approved this year. Pharmacists well understand that medication is part of the daily lives of many Americans. WASHINGTON – The Supreme Court ruled unanimously Thursday that states can regulate pharmacy benefit managers, the prescription drug "middlemen" … The approval was based on the ongoing single-arm, open-label ZUMA-2 trial. “CPhA has had a good working relationship with the California Department of Justice, of which he was the Attorney General,” she said. Just like that, 2019 is coming to a close and what a year it has … About 8% of patients who have this dystrophy have a confirmed mutation amenable to exon 53 skipping. Two owners of a dozen New York City-area pharmacies have been charged for their reported involvement in a $30 million health care fraud and money laundering scheme, a … Kentucky Board of Pharmacy News June 2020 Page 4 continued from page 1 prioritization. “In many cases, cancers are treated more as a chronic condition. Somapacitan-beco (Sogroya, NovoNordisk), given as a subcutaneous injection, is a new, long-acting growth hormone analog for adults with growth hormone deficiency. The St. Luke's PGY2 Pharmacotherapy residency program led by Heather Blue, assistant professor, … The posting of advertisements or solicitation of any kind is prohibited. Capmatinib (Tabrecta, Novartis) is an oral TKI approved for adults with metastatic or inoperable non-small cell lung cancer (NSCLC) with a mesenchymal-epithelial transition (MET) exon 14 skipping mutation. A Legacy to Help Others; A Legacy to Help Others. “In the past 10 years, there’s been a significant number of new options to treat patients with several specialty conditions,” Tharaldson said at the AMCP Nexus 2020 Virtual meeting, where she highlighted several that were approved this year. The biologic is used with pomalidomide and dexamethasone (pom-dex) to treat adults with multiple myeloma who have received at least two prior therapies. About 5,000 patients in the United States are diagnosed with GIST each year, “and approximately 10% have GIST caused by a mutation, which makes the cancer more aggressive and difficult to treat,” Tharaldson said. They will combine Dr. Fein’s expertise and cutting-edge analysis—such as this 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers—into training videos that will offer your team a thorough grounding in crucial industry topics. CDC’s Advisory Committee on Immunization Practices (ACIP) gave the vaccine its official recommendation on Saturday, December 12, and finalized its endorsement to prioritize COVID-19 vaccination for health care workers—including pharmacists—and residents of long-term-care facilities with the limited supply that will be available initially. Peanut allergen (arachis hypogaea) powder-dnfp (Palforzia, Aimmune Therapeutics) is an oral immunotherapy to prevent severe allergic reactions, including anaphylaxis from accidental peanut exposure. DEA registrants who experience theft or loss of CS would . Isatuximab-irfc was approved as an IV infusion given once weekly for four weeks, then every other week. The largest, most experienced publisher in the UK pharmacy sector. December 18, 2020 NORTH FORT MYERS, Fla. – A man with a knife was taken into custody after trying to rob a pharmacy inside a North Fort Myers Publix Thursday night. Brexucabtagene autoleucel (Tecartus, Kite/Gilead), a chimeric antigen receptor T-cell therapy, was approved as a one-time infusion for mantle cell lymphoma (MCL), and tafasitamab-cxix (Monjuvi, MorphoSys/Incyte) was approved as an IV infusion for large B-cell lymphoma. Another drug approved for NSCLS is selpercatinib (Retevmo, Loxo Oncology), an oral RET inhibitor, indicated for patients with RET-positive forms of the cancer. Of the patients with a response to sacituzumab govitecan-hziy, 55.6% maintained their response for six or more months and 16.7% maintained their response for 12 or more months. Amazon has filed to trademark “Amazon Pharmacy” in Canada, the U.K. and Australia, signaling a potential move into selling prescription drugs outside of the U.S. The Formative Four: Top Health IT Capabilities That Will Improve Medication... ‘Pandemic Nursing’ Is a Lethal Problem; ISMP Cites ‘Blame and Shame’ Culture, Pharmacists Prepare for COVID-19 Vaccine Cold-Chain Challenges, COVID-19–Associated Aspergillosis: A New Threat. On Friday, FDA granted an emergency use authorization (EUA) to a second COVID-19 vaccine—Moderna’s mRNA COVID-19 vaccine, which is indicated for individuals ages 18 years and older. In 2020, Drug Channels Institute will launch a new series of online training videos. CMS Pricing Transparency Rule Looms: Is Your Hospital Ready? Lonafarnib (Zokinvy, Eiger BioPharmaceuticals) was approved to reduce the risk for death from Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in patients aged 12 months and older. The approval was based on data from a multicenter single-arm study in 105 adult platinum-sensitive and -resistant patients with SCLC who had disease progression after treatment with platinum-based chemotherapy. In fact, about 30% of cancer drugs have an orphan drug designation, indicating a therapy for a condition that affects fewer than 200,000 people. It is a fixed-dose combination of oral decitabine, which is an anti-metabolite that has been available as an injectable form for about 15 years, with a new cytidine deaminase inhibitor. Feb 3, 2020, 1:36pm EST AmerisourceBergen Corp. is shutting down its compounding pharmacy business, Illinois-based PharMEDium, by the end of this year in a move that will impact … www.pharmacypracticenews.com Decitabine and cedazuridine (Inqovi, Taiho Oncology) is used to treat certain patients with myelodysplastic syndromes. SUBSCRIPTION. Sacituzumab govitecan-hziy also received orphan drug status in October, to treat glioblastoma. June 1, 2020 June 2020 news from faculty and staff of the College of Pharmacy Duluth. Ambulatory Care Review and Recertification Activities, Sterile Compounding Review and Recertification Activities, When you get your COVID-19 vaccine, you can thank this federal pharmacist, Second COVID-19 vaccine rolls out this week, ACIP issues more recommendations, Baricitinib plus remdesivir accelerates recovery from COVID-19, HHS Secretary nominee an ally for pharmacy, California Pharmacists Association says, With FDA clearing Pfizer’s COVID-19 vaccine, vaccination begins for frontline health care workers, FDA advisory panel gives green light to Pfizer vaccine, FDA advisory panel takes up Pfizer-BioNTech COVID-19 vaccine, Pfizer's vaccine offers strong protection after first dose, FDA OKs first COVID-19 and flu combo test, Britain launches the West's first mass coronavirus vaccination. Covering all major aspects of the pharmacy industry with breaking news, analysis … “Approximately 280,000 cases of invasive breast cancer are diagnosed annually and 17% overexpress HER2 protein,” Tharaldson said. However, this pharmacy partnership is being established in anticipation that one or more COVID-19 vaccines will be authorized or approved and recommended for use in the United States before the end of 2020. Fostemsavir (Rukobia, ViiV Healthcare) is a novel oral glycoprotein 120 attachment inhibitor used with other antiretrovirals for the treatment of multidrug-resistant HIV, which affects about 10,000 U.S. patients. December 18, 2020 NORTH FORT MYERS, Fla. – A man with a knife was taken into custody after trying to rob a pharmacy inside a North Fort Myers Publix Thursday night.